Normafenac (Cefuroxime Sodium)

Cefuroxime sodium inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the cross‑linking of peptidoglycan strands. This weakens the cell wall, causing osmotic rupture and death of susceptible bacteria.

The dose of Normafenac is individualized by the prescriber based on the type and severity of infection, patient age, weight, renal function and other clinical factors. No fixed regimen is provided here.

Safety data for cefuroxime sodium in pregnancy and lactation are limited. It should be used only if the expected benefit outweighs potential risks, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the Normafenac product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with earlier‑generation cephalosporins, cefuroxime offers broader Gram‑negative coverage and improved oral bioavailability (when formulated). It is often preferred over ampicillin for mixed infections, but clinicians may choose other agents based on local resistance patterns and patient‑specific factors.

Normafenac should be stored at 2‑8 °C, protected from light, and must not be frozen. Keep the vials in the original packaging to maintain stability and avoid exposure to moisture.

Normafenac is supplied as a sterile injectable solution for intramuscular or intravenous administration by a qualified healthcare professional. The route, infusion rate and dilution are determined by the prescribing clinician.

Serious adverse events include anaphylactic or severe hypersensitivity reactions, neutropenia or agranulocytosis, and Clostridioides difficile‑associated colitis. Patients should be monitored for signs of these conditions and receive prompt medical attention if they occur.

Normafenac is contraindicated in individuals with a known hypersensitivity to cefuroxime, other cephalosporins, or penicillins. Caution is also advised for patients with severe renal impairment unless dose adjustments are made.